A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.
about
Clinical applications of palifermin: amelioration of oral mucositis and other potential indicationsThe Efficacy of an Oral Elemental Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation.A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myelomaNot too little, not too much-just right! (Better ways to give high dose melphalan).Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials.
P2860
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase I dose-escalation tria ...... ma with normal renal function.
@en
A phase I dose-escalation tria ...... ma with normal renal function.
@nl
type
label
A phase I dose-escalation tria ...... ma with normal renal function.
@en
A phase I dose-escalation tria ...... ma with normal renal function.
@nl
prefLabel
A phase I dose-escalation tria ...... ma with normal renal function.
@en
A phase I dose-escalation tria ...... ma with normal renal function.
@nl
P2093
P2860
P1476
A phase I dose-escalation tria ...... oma with normal renal function
@en
P2093
Abhinav Deol
Jeffrey Zonder
Joseph Uberti
Judith Abrams
Lawrence Lum
Lois Ayash
Marie Ventimiglia
Nishant Tageja
Rishi Agarwal
Simon Cronin
P2860
P356
10.1016/J.BBMT.2012.08.003
P577
2012-08-11T00:00:00Z